Colin Baigent
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Predictive Value of Urine Tubular Biomarkers on Kidney Outcomes: Observations from EMPA-KIDNEY.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 15, 2026
Challenges in assessing statin-associated adverse events - Authors' reply.
Journal: Lancet (London, England)
Published: May 07, 2026
Erratum to "2025 Focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias" [Atherosclerosis, 409, (October 2025), 120479].
Journal: Atherosclerosis
Published: April 03, 2026
Effects of Sacubitril/Valsartan versus Irbesartan on Urine Tubular Biomarkers in Chronic Kidney Disease: Findings from the UK HARP-III Trial.
Journal: American journal of nephrology
Published: January 26, 2026
Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: October 31, 2025
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
Journal: Giornale italiano di cardiologia (2006)
Published: October 27, 2025
Estimating the long-term effects of aspirin for primary prevention.
Journal: European heart journal
Published: September 09, 2025
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.
Journal: Atherosclerosis
Published: August 30, 2025
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.
Journal: European heart journal
Published: August 29, 2025
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: August 27, 2025
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition.
Journal: Kidney international reports
Published: June 19, 2025
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: June 18, 2025
Last Updated: 09/26/2026